Kairos Pharma, Ltd. (KAPA)

Profile

Full Name

Kairos Pharma

Ticker

NYSEAmerican: KAPA

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 16, 2024

Indexes

Not included

Website

http://kairospharma.com

Employees

1

Key Details

Price

$0.93(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00

Annual EPS

-$0.23(-35.29% YoY)

PE ratio

-

Next earnings date

Aug 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.93
    KAPA price is $0.93

    30-Day Relative Volume

    0.05
    KAPA 30-day relative volume is 0.05

    Price Performance

    Price Most recent change

    0%
    KAPA price has remained unchanged on Jul 25, 2025

    Price YTD change

    -38.82%
    KAPA price is down -38.82% since January 1st

    Price 1-year change

    -
    KAPA price 1-year change is unknown

    Price 3-year change

    -
    KAPA price 3-year change is unknown

    Price Range

    Price All-time high

    $4.00
    KAPA price is currently -76.75% below its historical high of $4.00

    Price 3-year low

    $0.40
    KAPA price is currently +132.50% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $11.94M
    KAPA market capitalization is $11.94 million

    Market cap 3-year change

    -
    KAPA market capitalization 3-year change is unknown

    Market cap All-time high

    $33.39M
    KAPA market capitalization is currently -64.23% below its historical high of $33.39 million

    Market cap sector rank

    17.64%
    KAPA market capitalization is higher than 17.64% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.6%
    KAPA shares outstanding is up +0.6% year-on-year

    Shares Outstanding 3-Year Change

    -
    KAPA shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.22
    KAPA beta is 0.22

    200-day SMA

    $1.15
    KAPA price is currently -19.19% below its 200-day simple moving average

    50-day SMA

    $0.68
    KAPA price is currently +36.12% above its 50-day simple moving average

    RSI

    57.09
    KAPA 14-day relative strength index is 57.09

    Volume

    0.05
    KAPA 30-day relative volume is 0.05

    ATR

    $0.13
    KAPA average true range is $0.13

    10-day Historical Volatility

    375.53%
    KAPA 10-day historical volatility is 375.53%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    KAPA annual revenue is $0.00

    Revenue Analysts estimate

    -
    KAPA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    KAPA annual revenue 1-year change is unknown

    Revenue Sector rank

    1.14%
    KAPA annual revenue is higher than 1.14% of companies in Healthcare sector

    EPS

    EPS

    -$0.23
    KAPA annual earnings per share is -$0.23

    EPS Analysts estimate

    -$0.19
    KAPA annual earnings per share is currently +21.05% higher than the consensus analysts' forecast

    EPS 1-year change

    -35.29%
    KAPA annual earnings per share is down -35.29% year-on-year

    EPS Sector rank

    74.94%
    KAPA annual earnings per share is higher than 74.94% of companies in Healthcare sector

    Profit

    Gross profit

    -
    KAPA annual gross profit value is unknown

    Gross margin

    -
    KAPA annual gross profit margin value is unknown

    Operating profit

    -$2.34M
    KAPA annual operating income is -$2.34 million

    Operating margin

    -
    KAPA annual operating profit margin value is unknown

    Net income

    -$2.60M
    KAPA annual net profit is -$2.60 million

    Net margin

    -
    KAPA annual net profit margin value is unknown

    Expenses

    Total expenses

    $2.34M
    KAPA annual total expenses is $2.34 million

    Operating expenses

    $2.34M
    KAPA annual total operating expenses is $2.34 million

    Cost of goods sold

    -
    KAPA annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $1.77M
    KAPA annual SGA is $1.77 million

    Depreciation and amortization

    $160.00K
    KAPA annual depreciation & amortization is $160.00 thousand

    Interest expense

    $189.00K
    KAPA annual interest expense is $189.00 thousand

    Income tax

    -
    KAPA annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$2.41M
    KAPA annual earnings before interest & taxes is -$2.41 million

    EBITDA

    -$2.85M
    KAPA annual EBITDA is -$2.85 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.77M
    KAPA annual total assets is $5.77 million

    Non current assets

    $1.60M
    KAPA annual long term assets is $1.60 million

    Current assets

    $4.17M
    KAPA annual total current assets is $4.17 million

    Cash and cash equivalents

    $1.27M
    KAPA annual cash & cash equivalents is $1.27 million

    Accounts receivable

    -
    KAPA annual accounts receivable value is unknown

    Inventory

    -
    KAPA annual inventory value is unknown

    Liabilities

    Total liabilities

    $992.00K
    KAPA annual total liabilities is $992.00 thousand

    Long term liabilities

    $0.00
    KAPA annual total long term liabilities is $0.00

    Current liabilities

    $992.00K
    KAPA annual total current liabilities is $992.00 thousand

    Accounts payable

    $992.00K
    KAPA annual accounts payable is $992.00 thousand

    Debt

    Total debt

    -
    KAPA annual total debt value is unknown

    Total debt 1-year change

    -
    KAPA annual total debt 1-year change is unknown

    Long term debt

    -
    KAPA annual long term debt value is unknown

    Short term debt

    -
    KAPA annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $4.78M
    KAPA annual stockholders equity is $4.78 million

    Book value

    $4.55M
    KAPA annual book value is $4.55 million

    Retained earnings

    -$8.81M
    KAPA annual retained earnings is -$8.81 million

    Working capital

    $3.18M
    KAPA annual working capital is $3.18 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$3.96M
    KAPA annual cash flow from operations is -$3.96 million

    Cash from operations 1-year change

    -4982.72%
    KAPA annual cash flow from operations is down -4982.72% year-on-year

    Cash from investing

    -
    KAPA annual cash flow from investing activities value is unknown

    Cash from investing 1-year change

    -
    KAPA annual cash flow from investing activities 1-year change is unknown

    Cash from financing

    $5.13M
    KAPA annual cash flow from financing activities is $5.13 million

    Cash from financing 1-year change

    +1308%
    KAPA annual cash flow from financing activities is up +1308% year-on-year

    CAPEX

    CAPEX

    -
    KAPA annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    KAPA annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$3.96M
    KAPA annual free cash flow is -$3.96 million

    Free cash flow 1-year change

    -4982.72%
    KAPA annual free cash flow is down -4982.72% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    KAPA annual gross profit margin value is unknown

    Operating margin

    -
    KAPA annual operating profit margin value is unknown

    Net margin

    -
    KAPA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -45.13%
    KAPA annual return on assets is -45.13%

    ROE

    -54.50%
    KAPA annual return on equity is -54.50%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    KAPA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    KAPA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.72
    KAPA price to book ratio is 1.72

    PB ratio Sector rank

    50.29%
    KAPA price to book ratio is higher than 50.29% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    KAPA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    KAPA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    KAPA enterprise value value is unknown

    Enterprise value Sector rank

    -
    KAPA enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    KAPA EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    KAPA EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.20
    KAPA annual current ratio is 4.20

    Quick ratio

    -
    KAPA annual quick ratio value is unknown

    Leverage

    Debt to equity

    -
    KAPA annual debt to equity ratio value is unknown

    Interest coverage ratio

    -12.77
    KAPA annual interest coverage ratio is -12.77

    Risk & Stability

    Piotroski F-Score

    -
    KAPA piotroski f-score value is unknown

    Altman Z-Score

    4.36
    KAPA altman z-score is 4.36

    Analyst ratings

    Recent major analysts updates

    Jul 16, 25 D. Boral Capital
    Buy
    Jun 4, 25 D. Boral Capital
    Buy
    Apr 17, 25 D. Boral Capital
    Buy
    Apr 3, 25 HC Wainwright & Co.
    Buy
    Mar 31, 25 D. Boral Capital
    Buy
    Mar 27, 25 Maxim Group
    Buy
    Mar 20, 25 D. Boral Capital
    Buy
    Feb 26, 25 D. Boral Capital
    Buy
    Feb 18, 25 D. Boral Capital
    Buy
    Feb 12, 25 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with KAPA included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Kairos Pharma, Ltd.?
    • Does Kairos Pharma, Ltd. pay dividends?
    • What sector is Kairos Pharma, Ltd. in?
    • What industry is Kairos Pharma, Ltd. in?
    • What country is Kairos Pharma, Ltd. based in?
    • When did Kairos Pharma, Ltd. go public?
    • Is Kairos Pharma, Ltd. in the S&P 500?
    • Is Kairos Pharma, Ltd. in the NASDAQ 100?
    • Is Kairos Pharma, Ltd. in the Dow Jones?
    • When was Kairos Pharma, Ltd.'s last earnings report?
    • When does Kairos Pharma, Ltd. report earnings?

    What is the ticker symbol for Kairos Pharma, Ltd.?

    The ticker symbol for Kairos Pharma, Ltd. is NYSEAmerican:KAPA

    Does Kairos Pharma, Ltd. pay dividends?

    No, Kairos Pharma, Ltd. does not pay dividends

    What sector is Kairos Pharma, Ltd. in?

    Kairos Pharma, Ltd. is in the Healthcare sector

    What industry is Kairos Pharma, Ltd. in?

    Kairos Pharma, Ltd. is in the Biotechnology industry

    What country is Kairos Pharma, Ltd. based in?

    Kairos Pharma, Ltd. is headquartered in United States

    When did Kairos Pharma, Ltd. go public?

    Kairos Pharma, Ltd.'s initial public offering (IPO) was on September 16, 2024

    Is Kairos Pharma, Ltd. in the S&P 500?

    No, Kairos Pharma, Ltd. is not included in the S&P 500 index

    Is Kairos Pharma, Ltd. in the NASDAQ 100?

    No, Kairos Pharma, Ltd. is not included in the NASDAQ 100 index

    Is Kairos Pharma, Ltd. in the Dow Jones?

    No, Kairos Pharma, Ltd. is not included in the Dow Jones index

    When was Kairos Pharma, Ltd.'s last earnings report?

    Kairos Pharma, Ltd.'s most recent earnings report was on May 14, 2025

    When does Kairos Pharma, Ltd. report earnings?

    The next expected earnings date for Kairos Pharma, Ltd. is August 29, 2025
    On this page